Evidence tells us patients labeled with a penicillin allergy often experience longer inpatient lengths of stay and higher costs. In addition, they’re often at higher risk for developing serious infections including Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci. We also know that minimizing unnecessary exposure to antimicrobials — particularly those that are penicillin-alternatives[ Read More ]
Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS is a Clinical Associate Professor at the University of Georgia College of Pharmacy. At St. Joseph/ Candler Health System, Dr. Bland's primary practice areas include Infectious Diseases and Internal Medicine.